---
title: "Zhang 2024 — Uncovering Taxonomic and Functional Alteration of Gut Microbiota in CKD through 16S rRNA Data"
type: source
created: 2026-04-09
updated: 2026-04-17
authors: [Yangyang Zhang, Weicong Zhong, Wenting Liu, Xiaohua Wang, Gan Lin, Jiawen Lin, Junxuan Fang, Xiangyu Mou, Shan Jiang, Jiayuan Huang, Wenjing Zhao, Zhihua Zheng]
year: 2024
journal: "Frontiers in Cellular and Infection Microbiology"
doi: "10.3389/fcimb.2024.1363276"
evidence_level: systematic-review-meta-analysis
sample_size: "n=980 (6 studies, 3 nations)"
tags: [chronic-kidney-disease, CKD, 16S-rRNA, gut-microbiota, Faecalibacterium-prausnitzii, biomarker, meta-analysis, functional-analysis]
library_category: signatures
platform: both
condition: "chronic-kidney-disease"
karen_brain_primitives: [1, 5]
metals_discussed: []
taxa_discussed: [faecalibacterium-prausnitzii]
key_findings:
  - "Substantial decrease in microbial diversity confirmed across 980 samples in CKD meta-analysis"
  - "F. prausnitzii significantly reduced in CKD and negatively correlated with pro-oxidant metabolic pathways"
  - "F. prausnitzii proposed as both biomarker and therapeutic target for CKD"
keystone: false
---

# Uncovering Taxonomic and Functional Alteration of Gut Microbiota in CKD

## Key Findings

- **Substantial decrease in microbial diversity** was confirmed in [[chronic-kidney-disease]] across a pooled dataset of 980 samples from six studies spanning three nations, providing robust cross-population validation (Zhang et al. 2024, systematic review/meta-analysis).
- **[[faecalibacterium-prausnitzii]] was significantly reduced** in CKD patients, confirming it as one of the most consistently depleted species across CKD microbiome studies.
- **F. prausnitzii abundance was negatively correlated** with three functional pathways regulating acid-base disturbance and pro-oxidant metabolism, suggesting mechanistic links between its depletion and CKD-associated metabolic derangements.
- **F. prausnitzii is proposed as both a preventive and therapeutic tool** for CKD -- as a biomarker for early detection and as a probiotic candidate for microbiome restoration.
- The meta-analytic approach using standardized bioinformatics (DADA2, QIIME2, PICRUSt2) strengthens conclusions by controlling for analytical variability across studies.

## Methods

- **Study design**: Comprehensive meta-analysis of publicly available 16S rRNA sequencing data
- **Sample size**: 980 samples aggregated from six independent studies across three nations
- **Bioinformatics**: Standardized pipeline using DADA2 for denoising, QIIME2 for analysis, and PICRUSt2 for functional prediction
- **Analysis**: Alpha/beta diversity, differential abundance at multiple taxonomic levels, correlation with predicted functional pathways
- **Strength**: Cross-population validation; standardized analytical pipeline reduces inter-study variability
- **Limitations**: 16S resolution; functional predictions are inferred (PICRUSt2), not directly measured; public data may have variable clinical phenotyping

## Detailed Summary

Zhang et al. applied a standardized bioinformatics pipeline to pooled 16S rRNA data from six CKD studies, providing the most rigorous meta-analysis of CKD-associated microbiome changes at the 16S level. The F. prausnitzii finding is the centerpiece: this major butyrate producer is consistently depleted across CKD cohorts worldwide, and its absence correlates with specific functional pathway disruptions -- particularly those involved in acid-base regulation and oxidative metabolism. Since CKD is characterized by metabolic acidosis and oxidative stress, the F. prausnitzii-pathway correlations suggest a mechanistic model: loss of F. prausnitzii reduces butyrate availability, which impairs colonocyte energy metabolism, shifts the luminal environment toward oxidation and acidification, and further selects against obligate anaerobes, creating a self-reinforcing decline. This positions F. prausnitzii as a keystone species in the CKD gut ecosystem, consistent with Wang 2023's identification of Ruminococcus bromii as another CKD keystone.

## Relevance to WikiBiome

The highest evidence level (systematic review/meta-analysis) supporting F. prausnitzii depletion as a hallmark of CKD dysbiosis. Essential for the **[[faecalibacterium-prausnitzii]]** entity page -- this study provides the most robust evidence for its clinical significance in CKD. Supports concept pages on [[dysbiosis]] and SCFA metabolism in renal disease.

## Relevance to Cureva

Top-tier evidence (Primitive 1, 5) supporting F. prausnitzii restoration as a therapeutic strategy in CKD. The functional pathway correlations provide mechanistic justification for the intervention: restoring F. prausnitzii should reduce oxidative stress and improve acid-base homeostasis. This generates a specific intervention hypothesis for triangle validation. Complements the dietary fiber evidence (Yang 2021) -- fiber supplementation may work in part by feeding F. prausnitzii.

## Open Questions

- Can F. prausnitzii supplementation directly improve CKD biomarkers in clinical trials?
- Which F. prausnitzii strains have the highest butyrate-producing capacity in the uremic environment?
- Does F. prausnitzii colonization require concurrent environmental modification (pH, fiber) to succeed in the CKD gut?
